How New FDA Guidance Project Optimus May Affect Future of Oncology Clinical Trials, Drug Pipeline Article 新しい米国FDAガイダンスのプロジェクト・オプティマスが、オンコロジー臨床試験、医薬品パイプラインの今後に及ぼす可能性のある影響について Julie Bullock, VP, global head of clinical pharmacology and translational medicine at Certara, discusses the…Certara2021年8月16日
Fundamentals of regulatory writing: the document development process Article Fundamentals of regulatory writing: the document development process Regulatory writers lead the development of high-quality regulatory documents by working incollaboration with colleagues across…Certara2021年6月22日
Legislators: Bring all stakeholders to the table to lower drug costs Article Legislators: Bring all stakeholders to the table to lower drug costs BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…Certara2021年3月30日
Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge? 記事 Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge? By Professor Piet van der Graaf, Ph.D., and Hugo Geerts, Ph.D. Neurodegenerative diseases (NDs) affect…Certara2021年3月10日
Scientific Computing World: Connecting Science Article Scientific Computing World: Connecting Science Interconnection is an imperative for the modern laboratory, and seamless integration is mandatory from the…Certara2021年3月4日
Certara’s Phoenix software supports training of the next generation of the pharmacometricians in China Article Certara’s Phoenix software supports training of the next generation of the pharmacometricians in China The Pharmacy department of the Shanghai Chest Hospital is dedicated to developing and applying model-informed…Certara2020年12月3日
Getting Real with RWE Article Getting Real with RWE By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…Certara2020年11月20日
How PBPK Modeling Can Replace Drug-Drug Interaction Studies Article 薬物間相互作用試験の代わりに、PBPKモデリングをどのように使用できるか Patients often take more than one drug at a time, especially elderly patients and those…Certara2020年11月12日
PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue Article PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue Certara2020年7月20日
Clinical Pharmacology—The Quarterback of Drug Development Article Clinical Pharmacology—The Quarterback of Drug Development Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…Certara2017年8月14日